J Rouffy

490 total citations
62 papers, 397 citations indexed

About

J Rouffy is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Cancer Research. According to data from OpenAlex, J Rouffy has authored 62 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Surgery, 11 papers in Cardiology and Cardiovascular Medicine and 9 papers in Cancer Research. Recurrent topics in J Rouffy's work include Lipoproteins and Cardiovascular Health (17 papers), Cancer, Lipids, and Metabolism (8 papers) and Lipid metabolism and disorders (6 papers). J Rouffy is often cited by papers focused on Lipoproteins and Cardiovascular Health (17 papers), Cancer, Lipids, and Metabolism (8 papers) and Lipid metabolism and disorders (6 papers). J Rouffy collaborates with scholars based in France. J Rouffy's co-authors include J Jaillard, B. Chanu, David Upmalis, Marie‐Paule Dain, C Dreux, J Loeper, Dominique Farge, F. Sauvaget, E Turpin and Dominique Néel and has published in prestigious journals such as Gastroenterology, The American Journal of Medicine and European Heart Journal.

In The Last Decade

J Rouffy

56 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Rouffy France 10 159 129 102 61 56 62 397
Keane Wf United States 12 183 1.2× 136 1.1× 138 1.4× 69 1.1× 34 0.6× 18 617
N Chetty South Africa 14 106 0.7× 74 0.6× 100 1.0× 36 0.6× 47 0.8× 27 460
Z. Sangiorgi Italy 7 126 0.8× 88 0.7× 93 0.9× 52 0.9× 15 0.3× 16 408
Alberto Casaretto United States 7 107 0.7× 122 0.9× 55 0.5× 80 1.3× 27 0.5× 8 432
J N Mount United Kingdom 10 122 0.8× 114 0.9× 51 0.5× 67 1.1× 19 0.3× 14 501
M Liron Israel 10 157 1.0× 204 1.6× 155 1.5× 74 1.2× 16 0.3× 27 483
Kellie Sara Duffett Carlson Sweden 6 184 1.2× 199 1.5× 108 1.1× 50 0.8× 16 0.3× 9 438
Tomas Lenz Germany 12 119 0.7× 118 0.9× 242 2.4× 48 0.8× 36 0.6× 28 602
Naoyasu Maeda Japan 9 130 0.8× 66 0.5× 140 1.4× 37 0.6× 21 0.4× 12 349
Mai Ots Estonia 13 82 0.5× 91 0.7× 228 2.2× 77 1.3× 39 0.7× 19 579

Countries citing papers authored by J Rouffy

Since Specialization
Citations

This map shows the geographic impact of J Rouffy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Rouffy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Rouffy more than expected).

Fields of papers citing papers by J Rouffy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Rouffy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Rouffy. The network helps show where J Rouffy may publish in the future.

Co-authorship network of co-authors of J Rouffy

This figure shows the co-authorship network connecting the top 25 collaborators of J Rouffy. A scholar is included among the top collaborators of J Rouffy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Rouffy. J Rouffy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Montestruc, François, et al.. (1997). [Double-blind randomized comparative study of nicergoline naftidrofuryl on the quality of life in chronic obliterative arteriopathy of lower limbs with intermittent claudication].. PubMed. 52(3). 179–86. 4 indexed citations
2.
Sauvaget, F., et al.. (1996). Colonic ischemia reveals thromboangiitis obliterans (Buerger's disease). Gastroenterology. 110(3). 900–903. 32 indexed citations
3.
Chanu, B., et al.. (1995). [Acute rhabdomyolysis associated with digestive disorders during a voluntary overdose of ciprofibrate].. PubMed. 19(2). 231–2. 1 indexed citations
4.
Rouffy, J, et al.. (1993). Transformation maligne des ulcères des membres inférieurs. La Revue de Médecine Interne. 14(1). 51–53. 11 indexed citations
5.
Rouffy, J, et al.. (1993). Effects on blood lipid and androgen levels of two triphasic oral contraceptives.. PubMed. 38 Suppl 3. 114–6. 1 indexed citations
6.
Sauvaget, F., et al.. (1993). Colite ischémique révélatrice d'une maladie de Buerger. La Revue de Médecine Interne. 14(10). 1050–1050. 1 indexed citations
7.
Emmerich, Joseph, Isabelle Aubert, B. Bauduceau, et al.. (1990). Efficacy and safety of simvastatin (alone or in association with cholestyramine). A 1-year study in 66 patients with type II hyperlipoproteinaemia. European Heart Journal. 11(2). 149–155. 12 indexed citations
9.
Aubert, Isabelle, Joseph Emmerich, B. Chanu, et al.. (1988). [Effects of simvastatin on plasma lipids, lipoproteins and apoproteins (A1 and B). 24 cases of major primary hypercholesterolemia].. PubMed. 17(18). 901–4. 7 indexed citations
10.
Rouffy, J, et al.. (1986). [Pseudophlebitis of the lower limbs. A critical study from 102 suspected cases of deep venous thrombosis].. PubMed. 137(6). 488–92. 1 indexed citations
11.
Aubert, Isabelle, et al.. (1985). [Sea-blue histiocytes and storage diseases. 3 cases].. PubMed. 136(2). 133–6. 4 indexed citations
12.
Rouffy, J, et al.. (1985). Effects of Labetalol (400 mg/day) on Plasma Lipids, Lipoproteins and Apolipoproteins in Hypertensive Patients. Journal of Hypertension. 3(5). 545–545. 2 indexed citations
13.
Rouffy, J, et al.. (1985). Comparative evaluation of the effects of ciprofibrate and fenofibrate on lipids, lipoproteins and apoproteins A and B. Atherosclerosis. 54(3). 273–281. 22 indexed citations
14.
Rouffy, J & J Jaillard. (1984). Comparative effects of prazosin and atenolol on plasma lipids in hypertensive patients. The American Journal of Medicine. 76(2). 105–108. 59 indexed citations
15.
Rouffy, J, et al.. (1982). Xanthelasma et dyslipoprotéinémies: présentation de deux études rétrospectives.. Annales de Dermatologie et de Vénéréologie. 109(3). 1 indexed citations
16.
Rouffy, J, et al.. (1981). [Tendinous hyperlipoproteinaemic xanthomatosis associated with supravalvular aortic xanthomatosis (author's transl)].. PubMed. 132(5). 316–8.
17.
Rouffy, J, et al.. (1976). Atilipidemic drugs. Part 5: Evaluation of the hypolipidemic effect of LF 178 in 191 patients affected by the atherogenic form of endogenous hyperlipoproteinemia (types IIa, IIb and IV).. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 26(5). 901–6. 4 indexed citations
18.
Rouffy, J. (1975). [Effect of tiadenol in prolonged therapy of hyperlipoproteinemias (type IIa-IIb)].. PubMed. 30(6). 815–23. 3 indexed citations
19.
Rouffy, J, et al.. (1971). [Ileal bypass, surgical therapy of major pure hypercholesteremia (apropos of 2 cases)].. PubMed. 97(1). 57–63. 5 indexed citations
20.
Loeper, J, et al.. (1971). [Mixed hyperlipemia (apropos of 231 cases)].. PubMed. 122(5). 551–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026